Investigation of the antidiuretic effect of high doses of intravenous chlorpropamide during excessive solute excretion induced by the combination of furosemide and clopamide in patients with diabetes insipidus.
D000577:Amides / Q000627:therapeutic use*; D002747:Chlorpropamide / Q000008:administration & dosage / Q000627:therapeutic use*; D003005:Clopamide / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000188:drug therapy*; D004231:Diuresis; D004232:Diuretics / Q000627:therapeutic use; D004357:Drug Synergism; D005665:Furosemide / Q000627:therapeutic use*; D005919:Glomerular Filtration Rate; D006801:Humans; D007275:Injections, Intravenous; D007668:Kidney / Q000503:physiopathology; D007677:Kidney Function Tests; D007678:Kidney Glomerulus / Q000503:physiopathology; D007684:Kidney Tubules / Q000503:physiopathology; D010880:Piperidines / Q000627:therapeutic use*; D013997:Time Factors
D000577:Amides; D004232:Diuretics; D010880:Piperidines; D003005:Clopamide; D005665:Furosemide; D002747:Chlorpropamide